CDH17 and neoplasm: Specifically, low levels of CDH17 immunohistochemical expression in the tumor core were significantly more correlated with the presence of EPNI, whereas high levels of CDH17 immunohistochemical expression were significantly more correlated with a low score of Bd (Bd1).